Mercer Global Advisors
RDHL

Mercer Global Advisors’s Redhill Biopharma RDHL Stock Holding History

Mercer Global Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26
Closed -$4K – 2027
2022
Q4 		$4K Hold
26
– – ﹤0.01% 1923
2022
Q3 		$13K Sell
26
-1
-4% -$871 ﹤0.01% 1802
2022
Q2 		$23K Hold
27
– – ﹤0.01% 1796
2022
Q1 		$67K Hold
27
– – ﹤0.01% 1819
2021
Q4 		$69K Buy
27
+1
+4% +$4K ﹤0.01% 1741
2021
Q3 		$119K Hold
26
– – ﹤0.01% 1673
2021
Q2 		$179K Hold
26
– – ﹤0.01% 1585
2021
Q1 		$191K Hold
26
– – ﹤0.01% 1493
2020
Q4 		$211K Hold
26
– – ﹤0.01% 1218
2020
Q3 		$266K Buy
+26
New +$213K ﹤0.01% 1007

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Mercer Global Advisors's RDHL Position: Q1 2023 in Review

Mercer Global Advisors sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 26 shares — an estimated $4K sold.

Mercer Global Advisors first reported a position in RDHL in Q3 2020 and held it in 10 quarters. The position peaked at $266K in Q3 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Mercer Global Advisors reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Mercer Global Advisors sold 26 Redhill Biopharma shares in Q1 2023, an estimated $4K.
  • Mercer Global Advisors first reported a position in Redhill Biopharma in Q3 2020 and held it in 10 quarters.
  • Mercer Global Advisors's Redhill Biopharma position peaked at $266K in Q3 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Mercer Global Advisors's 13F filing for Q1 2023, filed 16 May 2023.